Vivozon Pharmaceutical Co., Ltd.

KOSDAQ:A082800 Stock Report

Market Cap: ₩147.7b

Vivozon Pharmaceutical Past Earnings Performance

Past criteria checks 0/6

Vivozon Pharmaceutical's earnings have been declining at an average annual rate of -3.1%, while the Semiconductor industry saw earnings growing at 14.2% annually. Revenues have been growing at an average rate of 9.5% per year.

Key information

-3.1%

Earnings growth rate

7.4%

EPS growth rate

Semiconductor Industry Growth23.5%
Revenue growth rate9.5%
Return on equity-1.9%
Net Margin-2.6%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Some Shareholders Feeling Restless Over Vivozon Pharmaceutical Co., Ltd.'s (KOSDAQ:082800) P/S Ratio

Jun 04
Some Shareholders Feeling Restless Over Vivozon Pharmaceutical Co., Ltd.'s (KOSDAQ:082800) P/S Ratio

We Think Vivozon Pharmaceutical (KOSDAQ:082800) Has A Fair Chunk Of Debt

Mar 23
We Think Vivozon Pharmaceutical (KOSDAQ:082800) Has A Fair Chunk Of Debt

Is Vivozon Healthcare (KOSDAQ:082800) A Risky Investment?

May 06
Is Vivozon Healthcare (KOSDAQ:082800) A Risky Investment?

Estimating The Intrinsic Value Of Vivozon Healthcare, Inc. (KOSDAQ:082800)

Feb 18
Estimating The Intrinsic Value Of Vivozon Healthcare, Inc. (KOSDAQ:082800)

Did You Miss Vivozon Healthcare's (KOSDAQ:082800) Impressive 116% Share Price Gain?

Dec 04
Did You Miss Vivozon Healthcare's (KOSDAQ:082800) Impressive 116% Share Price Gain?

Revenue & Expenses Breakdown

How Vivozon Pharmaceutical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KOSDAQ:A082800 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2477,515-1,98825,5262,999
31 Dec 2371,318-2,21422,6932,541
30 Sep 2363,298-15,14926,4152,783
30 Jun 2358,660-16,97526,5002,629
31 Mar 2351,411-20,94727,0852,322
31 Dec 2251,564-26,07927,7441,927
30 Sep 2252,429-65,74627,0271,777
30 Jun 2252,846-72,47229,0891,781
31 Mar 2257,175-69,52331,0963,834
31 Dec 2157,560-69,45731,6823,935
30 Sep 2156,999-47,72828,0475,721
30 Jun 2151,123-41,49221,5865,388
31 Mar 2148,923-39,36616,3863,092
31 Dec 2043,592-43,75410,8082,870
30 Sep 2040,671-30,8294,525363
31 Dec 1944,953-21,6314,931380
30 Sep 1944,701-9758,340400
30 Jun 1943,254-9,3928,583402
31 Mar 1945,740-8,3137,306368
31 Dec 1846,003-8,5347,252360
30 Sep 13118,417-2,2295,1250
30 Jun 13130,145-9595,4090

Quality Earnings: A082800 is currently unprofitable.

Growing Profit Margin: A082800 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: A082800 is unprofitable, and losses have increased over the past 5 years at a rate of 3.1% per year.

Accelerating Growth: Unable to compare A082800's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A082800 is unprofitable, making it difficult to compare its past year earnings growth to the Semiconductor industry (-25%).


Return on Equity

High ROE: A082800 has a negative Return on Equity (-1.93%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.